Latest news with #HormoneReplacementTherapy
India.com
13 hours ago
- Health
- India.com
Anaya Bangar to seek ICC, BCCI backing for Transgender participation in cricket, says 'I am eligible for women's cricket'
Anaya Bangar. New Delhi: The daughter of a former India cricketer, Sanjay Bangar, Anaya Bangar has urged the ICC and the BCCI to show support to the transgender athletes. Once Aryan, now Anaya, posted an eight-page report of athlete testing on Instagram detailing her transition experience after a year of the Hormone Replacement Therapy (HRT). On one of the videos posted on the platform, she shared that she was eligible to play women cricket and she talked of how she partnered with Manchester Metropolitan University in the process. The 23-year-old also revealed that Manchester Metropolitan University checked her muscle power, endurance, glucose as well as oxygen levels and compared their values to those of cisgender female athletes. All her parameters were within a normal range as per the reports compared to those of cisgender female athletes. View this post on Instagram A post shared by Anaya Bangar (@anayabangar) 'For the first time, I'm sharing the scientific report that documents my journey as a trans woman athlete. Over the past year, I've undergone structured physiological assessments after starting hormone therapy. This report captures the real, measurable impact of my transition not opinions, not assumptions, but data,' Anaya can be heard as saying in the video. 'I'm submitting this to the BCCI and ICC, with full transparency and hope. My only intention is to start a conversation based on facts not fear. To build space, not divide it. Whether you agree or not, thank you for witnessing,' she added. 'Science kehta hai main women's cricket ke liye eligible hoon. Ab sawaal yeh hai kya duniya tayyar hai sach sunne ke liye? (Science says I am eligible for women's cricket. Now, the question is whether the world ready to accept the truth?' Anaya captioned the video. Currently transgender cricketers have been denied the right to take part in women cricket. The ICC made this limitation at a board meeting, which was held after the end of the 2023 Cricket World Cup. Anaya had a hormonal replacement therapy and gender reaffirming surgery last year and he now resides in the United Kingdom.
NDTV
a day ago
- Health
- NDTV
"I Am Eligible For Women's Cricket": Anaya Bangar To Approach ICC, BCCI For Inclusion Of Transgender Athletes
Anaya Bangar, child of former India batter Sanjay Bangar, has urged the International Cricket Council (ICC) and the Board of Control for Cricket in India (BCCI) to support transgender cricketers. Anaya, who was formerly named Aryan, shared an eight-page athlete testing report detailing her journey as an athlete, post Hormone Replacement Therapy (HRT). Taking to Instagram, Anaya shared a video and revealed that she is eligible to take part in women's cricket. In the video, Anaya revealed that she collaborated with the Manchester Metropolitan University after completing a year of HRT. The 23-year-old added that the University conducted a test to collect data on her muscle power, endurance, glucose, and oxygen levels, comparing them with cisgender female athletes. As per the test reports, the parameters fell within cisgender female athlete norms. "For the first time, I'm sharing the scientific report that documents my journey as a trans woman athlete. Over the past year, I've undergone structured physiological assessments after starting hormone therapy. This report captures the real, measurable impact of my transition not opinions, not assumptions, but data," Anaya can be heard as saying in the video. "I'm submitting this to the BCCI and ICC, with full transparency and hope. My only intention is to start a conversation based on facts not fear. To build space, not divide it. Whether you agree or not, thank you for witnessing," she added. "Science kehta hai main women's cricket ke liye eligible hoon. Ab sawaal yeh hai kya duniya tayyar hai sach sunne ke liye? (Science says I am eligible for women's cricket. Now, the question is whether the world ready to accept the truth?" Anaya captioned the video. View this post on Instagram A post shared by Anaya Bangar (@anayabangar) Currently, transgender cricketers are not eligible to take part in women's cricket. This ban was imposed during an ICC board meeting following the Cricket World Cup in 2023. Anaya underwent a hormonal replacement therapy and gender reaffirming surgery last year and lives in the United Kingdom currently.
Globe and Mail
10-06-2025
- Business
- Globe and Mail
Hormone Replacement Therapy Market Set to Grow at 6.48% CAGR Through 2030, Driven by Rising Demand
Hormone Replacement Therapy companies working in the market are Abbott, Novartis AG, Pfizer Inc., Merck KGaA, Bayer AG, Halozyme Therapeutics, Inc., Eli Lilly and Company, Viatris Inc., F. Hoffman-La Roche, Novo Nordisk A/S, Amgen Inc., Genentech, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Ascendis Pharma Endocrinology, Inc., Vista Pharma, Inc., Clarus Therapeutics, Inc., Gedeon Richter Plc, Endo International plc, and others. (Albany, USA) DelveInsight's ' Hormone Replacement Therapy Market Insights, Competitive Landscape, and Market Forecast–2030 ' report provides a comprehensive analysis of the global hormone replacement therapy (HRT) market, focusing on adoption trends, technological advancements, and market dynamics across key regions. The report examines market growth, offering historical and projected market sizes, revenue trends, and key factors driving the demand for HRT in managing hormonal imbalances. The report highlights the evolving landscape of hormone replacement therapies, exploring advancements in bioidentical hormones, transdermal delivery systems, and combination therapies that improve efficacy and patient compliance. It delves into how these innovations are enhancing treatment outcomes for conditions such as menopause, hypogonadism, thyroid disorders, and growth hormone deficiencies, providing safer and more personalized solutions. Additionally, the report evaluates the competitive landscape, profiling major players in the global HRT market while spotlighting emerging technologies and novel therapeutic approaches expected to drive future growth. It provides an in-depth review of ongoing clinical developments, regulatory progress, and recent product approvals, making it a vital resource for understanding the rapidly advancing field of hormone replacement therapy. Some of the key insights of the Hormone Replacement Therapy Market Report: The hormone replacement therapy market is projected to expand at a CAGR of 6.48% from 2024 to 2030. North America is estimated to hold a significant revenue share in the Hormone Replacement Therapy market. In September 2024, the FDA's Oncologic Drugs Advisory Committee (ODAC) recognized the favorable benefit-risk profile of PD-1 inhibitors, including TEVIMBRA® (tislelizumab-jsgr), for the first-line treatment of locally advanced or metastatic ESCC and G/GEJ cancers with PD-L1 >1%. In August 2024, the FDA approved Ascendis Pharma's Yorvipath (palopegteriparatide) as a parathyroid hormone replacement therapy for adults with hypoparathyroidism, with the first U.S. supply expected in early 2025. In June 2024, Mangoceuticals announced the development of proprietary Oral Dissolvable Tablet (ODT) formulations of Enclomiphene Citrate, Pregnenolone, and DHEA to restore hormonal balance and naturally boost testosterone levels in men. In May 2023, Astellas Pharma Inc. announced the U.S. Food and Drug Administration (FDA) approval for VEOZAH (fezolinetant) 45 mg once daily for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. VMS, characterized by hot flashes and/or night sweats, are common symptoms of menopause. In January 2022, Pfizer, Inc. and OPKO Health, Inc. received approval from the Ministry of Health, Labor and Welfare, Japan, for the commercialization of NGENLA to treat growth hormone disorders. This product was the next-generation long-acting growth hormone injection, with a treatment frequency of a once-a-week dosage. Key players in the global Hormone Replacement Therapy market include Abbott, Novartis AG, Pfizer Inc., Merck KGaA, Bayer AG, Halozyme Therapeutics, Inc., Eli Lilly and Company, Viatris Inc., F. Hoffman-La Roche, Novo Nordisk A/S, Amgen Inc., Genentech, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Ascendis Pharma Endocrinology, Inc., Vista Pharma, Inc., Clarus Therapeutics, Inc., Gedeon Richter Plc, Endo International plc, and others. Hormone Replacement Therapy Overview Hormone Replacement Therapy (HRT) is a widely used treatment designed to replenish hormones that naturally decline due to aging or specific medical conditions. It is commonly prescribed for menopause-related symptoms in women, such as hot flashes, osteoporosis, and mood swings, as well as for hypogonadism and testosterone deficiency in men. Additionally, HRT plays a crucial role in managing conditions like hypothyroidism and growth hormone deficiencies. The therapy is available in various forms, including oral tablets, patches, injections, and topical gels, allowing personalized treatment approaches. Advancements in hormone formulations, including bioidentical and plant-derived hormones, have improved safety and efficacy, addressing concerns related to long-term use. Increasing awareness of hormonal imbalances and their impact on overall health is driving demand for HRT, making it a significant segment in the global healthcare market. Hormone Replacement Therapy Market Segment Analysis: The Hormone Replacement Therapy market report offers market segment analysis for the forecast period 2024-2030, segmented into: Hormone Replacement Therapy Market by Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Hormone Replacement, and Others) Hormone Replacement Therapy Market by Indication (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others) Hormone Replacement Therapy Market by Route of Administration (Oral, Parenteral, and Transdermal) Hormone Replacement Therapy Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World) Download the Hormone Replacement Therapy Market Analysis report for key market trends, innovations, and growth drivers. Hormone Replacement Therapy Market Dynamics One of the key factors driving the growth of the hormone replacement therapy market is the increasing awareness among women about managing menopausal symptoms. As women age, estrogen and progesterone levels decline significantly, leading to hormonal imbalances. In response, the pituitary gland increases follicle-stimulating hormone (FSH) production, causing symptoms such as hot flashes, excessive sweating, and palpitations. With a growing global population of women reaching menopause, the demand for hormone replacement therapy to manage these symptoms is expected to rise. Additionally, ongoing research and development efforts by key pharmaceutical companies are driving the discovery of novel treatments for hormonal imbalances. The increasing number of product approvals is further expanding the availability of hormone replacement therapies. Several companies are actively investing in the introduction of innovative therapies for conditions such as growth hormone deficiency and testosterone replacement, enhancing treatment options for both men and women. However, certain challenges may hinder market growth. The high costs associated with drug development, potential side effects linked to long-term hormone therapy use, and stringent regulatory approval processes remain significant barriers. Despite these challenges, the overall hormone replacement therapy market is expected to expand steadily, driven by advancements in treatment options and increasing patient awareness. North America Set to Lead the Growth of the Global Hormone Replacement Therapy Market North America is expected to dominate the hormone replacement therapy market, driven by the increasing demand for hormone replacement drugs among women due to the rising prevalence of menopausal-related issues. Additionally, the growing incidence of growth deficiencies, thyroid disorders, osteoporosis, and hypogonadism, along with active research and development efforts, is fueling market expansion in the region. The presence of key pharmaceutical companies, frequent product launches, and favorable reimbursement policies further support market growth. For instance, the increasing prevalence of thyroid-related conditions has led to a higher demand for hormone therapies, as these treatments play a crucial role in managing conditions like thyroid cancer and hormonal imbalances. Moreover, recent product relaunches and strategic collaborations among manufacturers are strengthening the market landscape. With these factors in play, North America is expected to maintain its leadership in the hormone replacement therapy market throughout the forecast period. Hormone Replacement Therapy Market Drivers Growing awareness of menopause-related health issues and a rising aging population are increasing the demand for HRT to manage symptoms like osteoporosis, cardiovascular risks, and hormonal imbalances. The development of safer, more effective hormone formulations, including bioidentical and plant-based options, has improved patient outcomes and increased adoption rates. Hormone Replacement Therapy Market Barriers Concerns about long-term HRT use, including increased risks of breast cancer, cardiovascular diseases, and stroke, limit patient adoption and regulatory approvals. The cost of HRT, especially newer formulations and customized therapies, can be a financial burden for patients, with limited insurance reimbursement restricting accessibility. To learn more about Hormone Replacement Therapy drivers and barriers, visit @ Hormone Replacement Therapy Competitive Landscape and Market Forecast Report Table of Contents 1. Hormone Replacement Therapy Market Report Introduction 2. Hormone Replacement Therapy Market Executive Summary 3. Competitive Landscape 4. Regulatory Analysis 5. Hormone Replacement Therapy Market Key Factors Analysis 6. Hormone Replacement Therapy Market Porter's Five Forces Analysis 7. Hormone Replacement Therapy Market Layout 8. Hormone Replacement Therapy Market Company and Product Profiles 9. KOL Views 10. Project Approach 11. About DelveInsight 12. Disclaimer & Contact Us About DelveInsight DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth. Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Ankit Nigam Email: Send Email Phone: +14699457679 Address: 304 S. Jones Blvd #2432 City: Albany State: New York Country: United States Website:
Time Business News
01-06-2025
- Health
- Time Business News
Benefits and Risks of Hormone Replacement Therapy in Brooklyn and Staten Island
Hormone Replacement Therapy (HRT) is a treatment many people use when their hormone levels drop or become unbalanced. This therapy is especially common among women going through menopause, but men with low testosterone can also benefit from it. In places like Brooklyn and Staten Island, more and more people are turning to Hormone Replacement Therapy to feel better and improve their health. Like any treatment, HRT has both benefits and risks. Knowing these can help people make smarter choices about their health. Hormone Replacement Therapy works by adding hormones to the body to make up for the ones that are low or missing. For women, this often means adding estrogen and sometimes progesterone. For men, it usually means taking testosterone. People in Brooklyn and Staten Island look for this therapy when they feel tired, moody, or have trouble sleeping. Hormone changes can also lead to weight gain, hot flashes, and low energy. HRT can help fix these problems and bring back a better quality of life. In Brooklyn, many wellness clinics offer Hormone Replacement Therapy. These clinics work with patients to test hormone levels and create a plan that fits their needs. Staten Island is also seeing a rise in clinics offering this treatment. Many people feel more comfortable using local services because they can get help quickly and easily. Hormone Replacement Therapy Brooklyn is a popular search online, showing that more people in the area are looking for answers and support. There are many health benefits linked to Hormone Replacement Therapy. One major benefit is how it helps reduce symptoms of menopause in women. These symptoms include night sweats, mood swings, and hot flashes. By using HRT, many women feel more like themselves again. For men, testosterone therapy can help improve strength, energy levels, and even mental focus. Another benefit of Hormone Replacement Therapy is how it helps with bone health. As people age, they can lose bone density, which leads to problems like osteoporosis. HRT helps keep bones strong, especially in post-menopausal women. In places like Brooklyn and Staten Island, where people want to stay active and healthy, this benefit is very important. Hormone Replacement Therapy Brooklyn doctors often recommend HRT for patients who have early signs of bone loss. Better sleep is another benefit people enjoy. Hormone changes can mess up sleep patterns, but HRT helps bring back a normal sleep cycle. With better sleep, people feel more rested and perform better at work or school. Mood also improves with steady hormone levels. That's why people who try HRT often report feeling happier and less anxious. While Hormone Replacement Therapy can be helpful, there are also risks. It's important for people in Brooklyn and Staten Island to talk with their doctors about these risks before starting treatment. One risk is that HRT may raise the chance of blood clots. This is more likely in women who take pills instead of patches or creams. It can also raise the risk of certain cancers, such as breast cancer, if used for many years. Heart problems are another concern. Some studies show that HRT may raise the risk of heart disease in older women. However, for younger women who start HRT close to the time they begin menopause, the risk may be smaller. That's why timing matters when it comes to this therapy. Doctors in Brooklyn who specialize in Hormone Replacement Therapy Brooklyn often review each patient's history before beginning any treatment. Other side effects can include bloating, headaches, and nausea. These symptoms may go away as the body gets used to the hormones. However, if they continue, a doctor may adjust the dose or change the type of hormone used. In Staten Island, some clinics offer personalized hormone treatments that lower the chances of bad side effects. Still, people should always keep track of how they feel and report any problems. There is no one-size-fits-all plan when it comes to Hormone Replacement Therapy. In Brooklyn and Staten Island, doctors work closely with patients to create the best plan based on age, health, and hormone levels. Some people may only need a small amount of hormone, while others need a mix of different types. Doctors also decide how the hormone should be given—through pills, patches, creams, or shots. Getting the right dose is key. Too much hormone can cause side effects, while too little may not help. That's why regular checkups and blood tests are needed. Clinics offering Hormone Replacement Therapy Brooklyn services often have advanced tools to monitor hormone levels closely. In Staten Island, some clinics even offer remote care, so patients can get help from home. It's also important to make healthy lifestyle changes when starting HRT. Eating well, exercising, and getting enough sleep all help make the treatment work better. Some clinics in Brooklyn and Staten Island offer programs that include wellness coaching along with hormone therapy. This way, patients get full support as they go through the process. Hormone Replacement Therapy isn't right for everyone, but many people in Brooklyn and Staten Island can benefit from it. Women going through menopause are often good candidates, especially if they have strong symptoms like hot flashes and mood swings. HRT can make a big difference in how they feel every day. Men with low testosterone who feel tired or weak may also benefit from the treatment. Before starting Hormone Replacement Therapy Brooklyn doctors will usually ask about health history. People with a history of cancer, blood clots, or heart disease might need to avoid HRT or use a different type. That's why an honest talk with a doctor is very important. The right doctor can help find a safe and effective plan for each person. Age matters too. The best time to start HRT is usually when symptoms first begin. For women, this is often in their late 40s or early 50s. For men, it can be later. Starting early helps lower the risk of long-term problems. Clinics in Staten Island often suggest starting with a low dose to see how the body reacts. If things go well, the dose can be slowly increased. Hormone Replacement Therapy has both benefits and risks. For many people in Brooklyn and Staten Island, the benefits—like better sleep, stronger bones, and improved mood—can make a big difference in their daily lives. However, it's important to understand the risks too. Talking with a doctor, getting regular checkups, and making healthy lifestyle choices can help make the treatment safer and more effective. Hormone Replacement Therapy Brooklyn clinics are seeing more people every year who want to feel better and live healthier. With the right plan and good care, HRT can be a powerful tool. But it should always be used carefully and with guidance from a medical professional. Whether you live in busy Brooklyn or quiet Staten Island, you deserve to feel your best. HRT might be the solution, but always be sure to learn as much as you can before making a choice. TIME BUSINESS NEWS
Yahoo
27-05-2025
- Entertainment
- Yahoo
Tracy Beaker star Dani Harmer reveals she's been diagnosed with perimenopause: ‘I felt like I was being possessed'
Tracy Beaker star Dani Harmer has revealed that she has been diagnosed with perimenopause after noticing symptoms related to her mental health. The 36-year-old actor, who rose to fame for her starring role in the CBBC TV adaptation of Jacqueline Wilson's novel The Story of Tracy Beaker, explained in a new TikTok video that she went to the doctors after experiencing brain fog, night sweats and difficulties with her mental health. In the video, Harmer pulled back some of her hair to reveal that her curly hair, which had become known as Tracy Beaker's signature locks, was thinning out as a result of the condition. 'I am losing it – it is thinning so badly you can see, like, the bald patches coming in, but just, like, the texture. It's thinning – it's bad, right?' she said. She added that the hair loss was 'getting me down' and that she was considering going to a salon to have curly hair extensions installed. Speaking about obtaining her diagnosis, Harmer revealed that it was her husband, Simon Brough, who encouraged her to get a diagnosis after her 'whole personality had pretty much changed'. 'There was just too much to ignore,' she said. 'I felt like I was being possessed by someone else; it was horrible – I was just getting deeper and deeper into a dark depression.' The actor is now managing her symptoms with the menopause treatment Hormone Replacement Therapy (HRT), which was prescribed after her doctor had run tests for different conditions, including cancer and coeliac disease. She said that the treatment has made her feel like herself again and that she had lost the weight that she had gained during lockdown, but her periods were 'all over the place'. Perimenopause is when a person has the symptoms of menopause but the periods have not stopped. The condition becomes menopause when a person fails to have a period for 12 months. Menopause is when periods stop due to lower hormone levels, which typically affects women between the ages of 45 and 55, but it can happen earlier. Menopause and perimenopause can cause symptoms like anxiety, mood swings, brain fog, hot flushes and irregular periods. These symptoms can start years before your periods stop and carry on afterwards. Harmer encouraged her fans who have had similar symptoms to seek medical advice and 'do not suffer', adding: 'Some of the symptoms are horrendous and you can spiral so quickly. I was really glad I went and got help.' The actor and her partner welcomed their first child, Avarie-Belle, in 2016. They had a second baby, Rowan, in 2022. Harmer appeared in The Story of Tracy Beaker from 2002 to 2005, before appearing in spin-offsTracy Beaker Returns (2009) and TheDumping Ground (2013).
